Tumor-Derived circRNAs as Circulating Biomarkers for Breast Cancer

Early diagnosis is the key to improving the prognosis of breast cancer (BC) patients; however, there are currently no circulating biomarkers that demonstrate good sensitivity and specificity. This study applied circular RNA (circRNA) microarray analysis, screening, and verification in BC plasma samp...

Descripción completa

Detalles Bibliográficos
Autores principales: Yu, Yunhe, Zheng, Wenfang, Ji, Changle, Wang, Xuehui, Chen, Mingkuan, Hua, Kaiyao, Deng, Xiaochong, Fang, Lin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8886293/
https://www.ncbi.nlm.nih.gov/pubmed/35242035
http://dx.doi.org/10.3389/fphar.2022.811856

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8886293/
https://www.ncbi.nlm.nih.gov/pubmed/35242035
http://dx.doi.org/10.3389/fphar.2022.811856

Ejemplares similares